Used in pharmaceutical synthesis as a chiral building block for developing bioactive molecules, particularly in the production of drug candidates targeting central nervous system disorders and metabolic diseases. Its protected amine group allows for selective reactions in multi-step organic syntheses, while the cyclopropylpiperazine structure enhances metabolic stability and receptor binding selectivity. Commonly employed in the development of kinase inhibitors and GPCR-targeted therapeutics.